Acute cadmium exposure reduces the local angiotensin I converting enzyme activity and increases the tissue metal content

Biological Trace Element Research

Volumn 166, Issue 2, 2015, Pages 149-156

  Broseghini Filho, Gilson B ^a   Almenara, Camila C Pereira ^a   Vescovi, Marcus V A ^a   Faria, Thaís de O ^a   Vassallo, Dalton V ^a,b   Angeli, Jhuli K ^a   Padilha, Alessandra S ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

Angiotensin I converting enzyme; Cadmium; Cadmium acute exposure; Local renin angiotensin system; Zinc

Indexed keywords

CADMIUM; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; MERCURY CHLORIDE; ZINC; MERCURY; METAL;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CADMIUM POISONING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; INTOXICATION; KIDNEY PARENCHYMA; LUNG PARENCHYMA; MALE; METALLATION; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; ENZYME ACTIVATION; KIDNEY; LUNG; METABOLISM; WISTAR RAT;

ANIMALS; AORTA; BLOOD PRESSURE; CADMIUM; ENZYME ACTIVATION; KIDNEY; LUNG; MALE; MERCURY; METALS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; ZINC;

EID: 84973408976     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0250-6     Document Type: Article

References (40)

1. Satarug S, Nishijo M, Ujjin P et al (2005) Cadmium-induced nephropathy in the development of high blood pressure. Toxicol Lett 157:57–68
2. Zhang W, Fievez L, Cheu E et al (2010) Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats. Eur J Pharmacol 628:171–178. doi: 10.1016/j.ejphar.2009.11.015
3. Nishijo M, Morikawa Y, Nakagawa H et al (2006) Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med 63:545–550. doi:10.1136/oem.2006.026591
4. Nawrot TS, Van Hecke E, Thijs L et al (2008) Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect 116:1620–1628. doi:10.1289/ehp.11667
5. Menke A, Muntner P, Silbergeld EK et al (2009) Cadmium levels in urine and mortality among U.S. adults. Environ Health Perspect 117: 190–196. doi:10.1289/ehp.11236
6. Vassallo DV, Simões MR, Furieri LB et al (2011) Toxic effects of mercury, lead and gadolinium on vascular reactivity. Brazilian J Med Biol Res 44:939–946. doi:10.1590/S0100-879X2011007500098
7. Afridi HI, Kazi TG, Kazi NG et al (2010) Evaluation of cadmium, lead, nickel and zinc status in biological samples of smokers and nonsmokers hypertensive patients. J Hum Hypertens 24:34–43. doi: 10.1038/jhh.2009.39
8. WHO World Health Organization. Cadmium (1992) Environmental Health Criteria 134. International Programme on Chemical Safety (IPCS), Geneve, Switzerland
9. Satarug S, Baker JR, Urbenjapol S, et al (2003) A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol Lett pp 65–83
10. Clemens S (2006) Toxic metal accumulation, responses to exposure and mechanisms of tolerance in plants. Biochimie 88:1707–1719. doi:10.1016/j.biochi.2006.07.003
11. Haswell-Elkins M, McGrath V, Moore M et al (2007) Exploring potential dietary contributions including traditional seafood and other determinants of urinary cadmium levels among indigenouswomen of a Torres Strait Island (Australia). J Expo Sci Environ Epidemiol 17: 298–306. doi:10.1038/sj.jes.7500547
12. Copes R, Clark NA, Rideout K et al (2008) Uptake of cadmium from Pacific oysters (Crassostrea gigas) in British Columbia oyster growers. Environ Res 107:160–169. doi:10.1016/j.envres.2008.01.014
13. Satarug S, Garrett SH, Sens MA, Sens DA (2010) Cadmium, environmental exposure, and health outcomes. Environ Health Perspect 118:182–190. doi:10.1289/ehp.0901234
14. Abu-Hayyeh S, Sian M, Jones KG et al (2001) Cadmium accumulation in aortas of smokers. Arterioscler Thromb Vasc Biol 21:863–867. doi:10.1161/01.ATV.21.5.863
15. Idée JM, Port M, Raynal I et al (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576. doi:10.1111/j.1472-8206.2006.00447.v
16. Sturrock ED, Natesh R, van Rooyen JM, Acharya KR (2004) Structure of angiotensin I-converting enzyme. Cell Mol Life Sci 61:2677–2686. doi:10.1007/s00018-004-4239-0
17. Lee MA, Paul M, Böhm M, Ganten D (1992) Effects of angiotensinconverting enzyme inhibitors on tissue renin-angiotensin systems. Am J Cardiol 70:12C–19C. doi:10.1016/0002-9149(92)91353-6
18. Simões MR, Ribeiro Júnior RF, Vescovi MV et al (2011) Acute lead exposure increases arterial pressure: role of the renin-angiotensin system. PLoS One 6:e18730. doi:10.1371/journal.pone.0018730
19. Sharifi AM, Darabi R, Akbarloo N et al (2004) Investigation of circulatory and tissue ACE activity during development of leadinduced hypertension. Toxicol Lett 153:233–238. doi:10.1016/j.toxlet.2004.04.013
20. Puri VN (1992) Acute effects of cadmium on the renin angiotensin system in rats. Biochem Pharmacol 44:187–188. doi:10.1016/0006- 2952(92)90056-O
21. Puri VN, Saha S (2003) Comparison of acute cardiovascular effects of cadmium and captopril in relation to oxidant and angiotensin converting enzyme activity in rats. Drug Chem Toxicol 26:213–218. doi:10.1081/DCT-120022646
22. Samani NJ, Morgan K, Brammar WJ, Swales JD (1987) Detection of renin messenger RNA in rat tissues: increased sensitivity using an RNAse protection technique. J Hypertens Suppl 5:S19–S21
23. Suzuki F, Ludwig G, Hellmann W et al (1988) Renin gene expression in rat tissues: a new quantitative assay method for rat renin mRNA using synthetic cRNA. Clin Exp Hypertens A 10:345–359. doi:10.3109/10641968809103531
24. Friedland J, Silverstein E (1976) A sensitive fluorimetric assay for serumangiotensin-converting enzyme. AmJ Clin Pathol 66:416–424
25. (ATSDR) Agency for Toxic Substances and Disease Registry (2008) Toxocological profile for cadmium
26. Varoni MV, Palomba D, Macciotta NP et al (2010) Brain reninangiotensin system modifies the blood pressure response to intracerebroventricular cadmium in rats. Drug Chem Toxicol 33:302–309. doi:10.3109/01480540903418496
27. Puri VN, Sur RN (1986) Effect of cadmium clonidine interaction in rats. Pharmacol Res Commun 18:1119–1122. doi:10.1016/0031-6989(86)90027-5
28. Lee MA, Paul M, Böhm M et al (1992) Effects of angiotensinconverting enzymei inhibitors on tissue renin-angiotensin systems. Am J Cardiol 70(10):12c–19c
29. Sparks MA, Crowley SD, Gurley SB et al (2014) Classical reninangiotensin systemin kidney physiology. Compr Physiol 4:1201–28. doi:10.1002/cphy.c130040
30. Fyhrquist F, Saijonmaa O (2008) Renin-angiotensin systemrevisited. J Intern Med 264:224–236. doi:10.1111/j.1365-2796.2008.01981.x
31. Nakamura Y, Nakamura K, Matsukura T (1988) Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril. J Hypertens 6:105–110
32. Angeli JK, Cruz Pereira CA, de Oliveira FT et al (2013) Cadmium exposure induces vascular injury due to endothelial oxidative stress: the role of local angiotensin II and COX-2. Free Radic Biol Med 65: 838–48. doi:10.1016/j.freeradbiomed.2013.08.167
33. Saxena PR (1992) Interaction between the renin-angiotensinaldosterone and sympathetic nervous systems. J Cardiovasc Pharmacol 19(Suppl 6):S80–S88. doi:10.1097/00005344-199219006-00013
34. Unger T, Ganten D, Lang RE (1987) Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications. Am J Cardiol 59:18D–22D. doi:10.1016/0002- 9149(87)90047-6
35. Ripa S, Ripa R (1994) Zinc and arterial pressure. Minerva Med 85: 455–459
36. Corot C, Idee JM, Hentsch AM et al (1998) Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme. J Magn Reson Imaging 8:695–702. doi:10.1002/jmri.1880080328
37. Carvalho E, Göthe PO, Bauer R et al (1995) Effect of inhibitors on the coordination geometries of cadmium at the metal sites in angiotensin-I-converting enzyme. Eur J Biochem 234:780–785
38. Balaraman R, Gulati OD, Bhatt JD et al (1989) Cadmium-induced hypertension in rats. Pharmacology 38:226–234. doi:10.1159/ 000138541
39. Skoczynska A, Stojek E (2005) The impact of subchronic lead poisoning on the vascular effect of nitric oxide in rats. Environ Toxicol Pharmacol 19:99–106. doi:10.1016/j.etap.2004.05.004
40. Houston M (2007) The role of mercury and cadmiumheavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Heal Med 128–134